Trusert HZ 40 mg+12.5 mg (Tablet)
Unit Price: ৳ 12.00 (3 x 10: ৳ 360.00)
Strip Price: ৳ 120.00
Medicine Details
Category | Details |
---|---|
Generic | Telmisartan hydrochlorothiazide |
Company | Ziska pharmaceuticals ltd |
Also available as |
Title & Categories
- Telmisartan and Hydrochlorothiazide
- Hypertension medication
- Antihypertensive combination drug
Dosage
- 80 mg/12.5 mg once daily
- 160 mg/25 mg after 2 to 4 weeks if necessary
- May be administered with other antihypertensive drugs
Indications
- Treatment of hypertension
- Lowering blood pressure
- Reducing the risk of cardiovascular events like strokes and myocardial infarctions
Pharmacology & Mode of Action
- Telmisartan: selective AT1 receptor blocker
- Vasoconstrictor and aldosterone-inhibiting effects
- No inhibition of ACE or binding to other hormone receptors
- Hydrochlorothiazide: thiazide diuretic affecting electrolyte reabsorption
Interaction & Contraindications
- Caution with aliskiren, digoxin, lithium, other high blood pressure medicines
- Interference with certain laboratory tests
- Contraindicated in known hypersensitivity
- Do not co-administer with Aliskiren in patients with Diabetes
Side Effects
- Dizziness
- Drowsiness
- Tired feeling
- Flushing
- Back pain
- Nausea
- Diarrhea
- Stomach pain
- Allergy
- Fever
- Leg pain
- Chest pain
- Insomnia
- Elevations of liver enzymes
- Leg cramps
- Myalgia
- Dermatitis
- Weakness
- Gastric irritation
- Photosensitivity
- Urticaria
- Muscle spasm
- Restlessness
Pregnancy & Lactation
- Pregnancy Category D
- Reduction in fetal renal function and increased fetal morbidity
- Potential neonatal adverse effects including hypotension, renal failure, and death
- Presence in human milk
- Thiazides appearing in human milk
Precautions & Warnings
- Medical history of kidney disease, liver disease, dehydration, mineral imbalance, gout, lupus
- Effect on blood sugar in diabetes patients
- Affect on potassium levels
- Potential dizziness
- Reporting prolonged diarrhea or vomiting
- Precaution while driving or using machinery
- Consultation before using potassium supplements or salt substitutes
Use in Special Populations
- Pediatric use: safety and effectiveness not established
- Geriatric use: cautious dose selection
- Use in patients with hepatic impairment under close medical supervision
- Use in patients with severe renal impairment not recommended
- No dose adjustment required in mild or moderate renal impairment
Overdose Effects
- Manifestations include hypertension, dizziness, tachycardia, bradycardia, electrolyte imbalances, dehydration
- Telmisartan is not removed by hemodialysis
- Degree of hydrochlorothiazide removal by hemodialysis not established
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Keep out of the reach of children
- Keep in a cool and dry place
- Protect from light
Related Brands
- Mitosan Plus 40 mg+12.5 mg (Tablet) - sandoz-a-novartis-division
- Mitosan Plus 80 mg+12.5 mg (Tablet) - sandoz-a-novartis-division
- Telcardis Plus 40 mg+12.5 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Telcardis Plus 80 mg+12.5 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Arbitel Plus 40 mg+12.5 mg (Tablet) - aci-limited